ACTINIUM PHARMACEUTICALS, INC. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2024-12-31 was 177.00K shares.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2024 was 500.00K shares, a 66.67% increase from fiscal 2023.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2023 was 300.00K shares, a 400.00% increase from fiscal 2022.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2022 was 60.00K shares, a 81.98% decline from fiscal 2021.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2021 was 333.00K shares.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2024-12-31 | 177.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 500.00K shares 10-K · filed 2025-03-31 |
| 2023-12-31 | 300.00K shares 10-K · filed 2025-03-31 | |
| 2022-12-31 | 60.00K shares 10-K · filed 2024-03-29 | |
| 2021-12-31 | 333.00K shares 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |